Clinical trial
Safety and Performance Evaluation of the NR600 System in Subjects With End-stage Inherited Outer Retinal Degenerative Diseases
NCT04295304 is registered in ClinicalTrials.gov with Nano Retina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Performance Evaluation of the NR600 System in Subjects With End-stage Inherited Outer Retinal Degenerative Diseases
- Lead sponsor
- Nano Retina
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- January 17, 2020
- Completion date
- March 12, 2023
- Enrollment
- 9 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.